VENUS REMEDIES
Quarterly Results Analysis [Mar2026]
VENUS REMEDIES Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹259 Cr | ₹180 Cr | ₹193 Cr | ₹132 Cr | ₹198 Cr | ₹177 Cr | ₹170 Cr | ₹109 Cr |
| Expenses | ₹196 Cr | ₹143 Cr | ₹162 Cr | ₹122 Cr | ₹166 Cr | ₹159 Cr | ₹163 Cr | ₹97 Cr |
| Operating Income | ₹63 Cr | ₹38 Cr | ₹31 Cr | ₹10 Cr | ₹32 Cr | ₹18 Cr | ₹8 Cr | ₹11 Cr |
| Other Income | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹9 Cr | ₹4 Cr | ₹2 Cr | ₹8 Cr | ₹2 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr |
| Profit Before Tax | ₹62 Cr | ₹33 Cr | ₹26 Cr | ₹13 Cr | ₹31 Cr | ₹25 Cr | ₹9 Cr | ₹7 Cr |
| Profit After Tax | ₹47 Cr | ₹26 Cr | ₹20 Cr | ₹10 Cr | ₹21 Cr | ₹20 Cr | ₹4 Cr | ₹1 Cr |
| EPS | ₹35.52 | ₹19.13 | ₹15.06 | ₹7.18 | ₹15.71 | ₹14.66 | ₹2.63 | ₹0.91 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VENUS REMEDIES | 2.9% | 84.3% | 301.6% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.4% | -4.5% | 6.5% |
| DIVIS LABORATORIES | 0.1% | -2.5% | -0.1% |
| TORRENT PHARMACEUTICALS | -2.7% | 1.2% | 39.3% |
| CIPLA | -2.3% | -5.3% | -9.8% |
| DR REDDYS LABORATORIES | -0.5% | -4.7% | -5.4% |
| MANKIND PHARMA | -0.3% | -5.3% | -0.9% |
| LUPIN | -0.3% | 0.6% | 12.3% |
| ZYDUS LIFESCIENCES | -4% | 7.1% | 10.2% |
VENUS REMEDIES Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 43.90 % |
| Y-o-Y | 31.24 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹259 Cr | 43.90 | |
| Dec2025 | ₹180 Cr | -6.48 | |
| Sep2025 | ₹193 Cr | 46.13 | |
| Jun2025 | ₹132 Cr | -33.27 | |
| Mar2025 | ₹198 Cr | 11.98 | |
| Dec2024 | ₹177 Cr | 3.77 | |
| Sep2024 | ₹170 Cr | 56.62 | |
| Jun2024 | ₹109 Cr | - | |
VENUS REMEDIES Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 69.06 % |
| Y-o-Y | 100.16 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹63 Cr | 69.06 | |
| Dec2025 | ₹38 Cr | 21.19 | |
| Sep2025 | ₹31 Cr | 206.53 | |
| Jun2025 | ₹10 Cr | -68.13 | |
| Mar2025 | ₹32 Cr | 75.86 | |
| Dec2024 | ₹18 Cr | 138.36 | |
| Sep2024 | ₹8 Cr | -32.86 | |
| Jun2024 | ₹11 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 17.49 % |
| Y-o-Y | 52.53 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 24.45% | 17.49 | |
| Dec2025 | 20.81% | 29.58 | |
| Sep2025 | 16.06% | 109.66 | |
| Jun2025 | 7.66% | -52.21 | |
| Mar2025 | 16.03% | 57.00 | |
| Dec2024 | 10.21% | 129.95 | |
| Sep2024 | 4.44% | -57.18 | |
| Jun2024 | 10.37% | - | |
VENUS REMEDIES Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 85.65 % |
| Y-o-Y | 126.14 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹47 Cr | 85.65 | |
| Dec2025 | ₹26 Cr | 27.07 | |
| Sep2025 | ₹20 Cr | 109.69 | |
| Jun2025 | ₹10 Cr | -54.29 | |
| Mar2025 | ₹21 Cr | 7.14 | |
| Dec2024 | ₹20 Cr | 458.40 | |
| Sep2024 | ₹4 Cr | 187.70 | |
| Jun2024 | ₹1 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 29.03 % |
| Y-o-Y | 72.41 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 18.31 % | 29.03 | |
| Dec2025 | 14.19 % | 35.92 | |
| Sep2025 | 10.44 % | 43.41 | |
| Jun2025 | 7.28 % | -31.45 | |
| Mar2025 | 10.62 % | -4.32 | |
| Dec2024 | 11.1 % | 438.83 | |
| Sep2024 | 2.06 % | 83.93 | |
| Jun2024 | 1.12 % | - | |
VENUS REMEDIES Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 85.68 % |
| Y-o-Y | 126.10 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹35.52 | 85.68 | |
| Dec2025 | ₹19.13 | 27.03 | |
| Sep2025 | ₹15.06 | 109.75 | |
| Jun2025 | ₹7.18 | -54.30 | |
| Mar2025 | ₹15.71 | 7.16 | |
| Dec2024 | ₹14.66 | 457.41 | |
| Sep2024 | ₹2.63 | 189.01 | |
| Jun2024 | ₹0.91 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD